| Literature DB >> 25006806 |
Shunji Natsuka1, Mayumi Masuda1, Wataru Sumiyoshi2, Shin-ichi Nakakita2.
Abstract
Entities:
Mesh:
Substances:
Year: 2014 PMID: 25006806 PMCID: PMC4090225 DOI: 10.1371/journal.pone.0102219
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Glycan map of 150 standard glycans.
White and black circles are N-linked and O-linked glycans, respectively. Data used for the plotting are listed in Table S1.
Figure 2Partial elution times of sugar residues of N-glycan on a reversed phase HPLC.
Partial elution time of each residue is written using symbols for the different types of monosaccharides. Circles indicate hexose, squares are GlcNAc, triangles are Fuc, the star is Xyl, and diamonds are NeuAc. Underlined letters are the residues, and the type of monosaccharides are followed: GN, GlcNAc; M, Man; G, Gal; X, Xyl; F, Fuc; Gc, Glc; S, NeuAc; BS, bisecting GlcNAc; CH, GlcNAc in N,N′-diacetylchitobiose core. The residues, X, GN3, GN4, and GN5 have two or three partial elution times corresponding to another specific residue. For example, the partial elution time of residue X is 4.7 when M2 residue exists and −0.5 when M2 is absent.
Figure 3Partial elution times of sugar residues of N-glycan on a size-fractionation HPLC.
The partial elution time of each residue is written using symbols for the different types of monosaccharides as the same manner in Figure 2.
Figure 4Separation of PA-glycans from human serum by three kinds of HPLCs.
(a) Elution profile of DEAE anion-exchange-chromatography. PA-N-glycans from human serum were separated into neutral (N) and acidic (A1–A4) fractions. The thick bar indicates the collected fractions. X indicates a peak derived from reagents. Arrows labeled S0–S4 indicate elution positions of standard PA-N-glycans with 0–4 sialic acids, respectively. Arrows O1 and O2 are those of 03N-core1 and 36N-core1, respectively. (b) Elution profile of size-fractionation HPLC. The fractions isolated by DEAE chromatography were separated further by size-fractionation HPLC, respectively. Arrowheads indicate the elution positions of PA-isomalto-oligosaccharides with degrees of polymerization from 1 to 20. Asterisked peak is an artificial glycan that details are mentioned in the text. (c) Elution profile of reversed-phase HPLC. The fractions isolated by DEAE chromatography were separated further by reversed phase HPLC, respectively. The insets labeled 10× are magnified 10-fold on vertical axis. Arrowheads indicate collected peaks. Double asterisked peak indicates a peak that is epimerization product from 66N-BI (peak A2-3).
Figure 5Two-dimensional HPLC map of the human serum PA-glycans.
The retention times on size-fractionation and reversed phase HPLC were converted to S and R values, respectively, as described in Materials and methods. Diameter of the circles is proportional to the cubic root of the detected amount of PA-glycans. Therefore, the quantity ratio of 100 times is approximately equal to the diameter ratio of 4.6 times. Data used for the plotting are listed in Table S3.
Figure 6Sialidase digestion of the human serum PA-glycans.
Plotting method is the same as Figure 5. Shifting of elution position of PA-glycans by Arthrobactor sialidase digestion are shown by arrows. Crosses are position of standard PA-glycans, which abbreviations are listed in Table S1. (a) A1 (monosialo), (b) A2 (disialo), (c) A3 (trisialo) and A4 (tetrasialo) PA-glycans.
Figure 7MS/MS analysis of desialylated A2-5b.
Parent ion (m/z 2252.887) was subjected to positive-mode MS/MS. Selected characteristic fragment ions are annotated and compatible structures are shown. Circles indicate hexose, and squares are N-acetylhexosamine. The fragment ions including pyridylamino residue are estimated to be derivatives from reducing end.